This page lists the SEC filings reported by BRATTON DOUGLAS K.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-13 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 5,750,882 | 4.2% | EDGAR |
| SC 13D/A | 2023-05-03 | BRATTON DOUGLAS K | MIDWEST HOLDING INC. | 445,171 | 11.9% | EDGAR |
| SC 13G/A | 2023-02-13 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 7,000,882 | 5.2% | EDGAR |
| SC 13G | 2022-12-21 | BRATTON DOUGLAS K | Altitude Acquisition Corp. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-12-13 | BRATTON DOUGLAS K | Altitude Acquisition Corp. | 70,573 | 4.2% | EDGAR |
| SC 13G | 2022-11-18 | BRATTON DOUGLAS K | American Acquisition Opportunity Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 7,845,189 | 6.4% | EDGAR |
| SC 13G/A | 2022-02-11 | BRATTON DOUGLAS K | Aquestive Therapeutics, Inc. | 3,468,747 | 8.6% | EDGAR |
| SC 13G/A | 2021-02-12 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 12,348,784 | 10.3% | EDGAR |
| SC 13G/A | 2021-02-09 | BRATTON DOUGLAS K | Aquestive Therapeutics, Inc. | 4,032,907 | 12.0% | EDGAR |
| SC 13D | 2020-05-04 | BRATTON DOUGLAS K | MIDWEST HOLDING INC. | 222,222,222 | 16.3% | EDGAR |
| SC 13G/A | 2020-02-12 | BRATTON DOUGLAS K | Aquestive Therapeutics, Inc. | 4,032,907 | 16.1% | EDGAR |
| SC 13G/A | 2020-02-11 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 20,415,535 | 21.3% | EDGAR |
| SC 13G | 2019-02-13 | BRATTON DOUGLAS K | Aquestive Therapeutics, Inc. | 4,032,907 | 16.2% | EDGAR |
| SC 13G | 2018-02-13 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 20,574,298 | 22.8% | EDGAR |
| SC 13D/A | 2018-02-07 | BRATTON DOUGLAS K | Juno Therapeutics, Inc. | 5,433,301 | 4.7% | EDGAR |
| SC 13D/A | 2017-11-08 | BRATTON DOUGLAS K | Juno Therapeutics, Inc. | 7,628,282 | 6.7% | EDGAR |
| SC 13D/A | 2017-07-18 | BRATTON DOUGLAS K | Juno Therapeutics, Inc. | 9,348,799 | 8.8% | EDGAR |
| SC 13D/A | 2016-03-03 | BRATTON DOUGLAS K | Juno Therapeutics, Inc. | 17,348,799 | 16.7% | EDGAR |
| SC 13D/A | 2015-06-25 | BRATTON DOUGLAS K | Juno Therapeutics, Inc. | 25,988,799 | 28.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.